The company won five Gold Medals for its pioneering probiotic and postbiotic solutions.
SynbioTech's scientifically validated breakthroughs in precision health earned high acclaim from the international panel of judges. The award-winning innovations include the following.
ABKEFIR: Developed using a proprietary "symbiotic fermentation" process, the innovative technology is verified to enhance antioxidant capacity, modulate immune response, and demonstrate a potent inhibitory effect against the common foodborne pathogen Salmonella typhimurium.
LDL557 Postbiotic: A novel solution proven to mitigate joint swelling, prevent cartilage matrix damage, and alleviate inflammatory responses.
SynForU-ReMain: An advanced formula that utilises the gut-kidney axis mechanism to provide adjunctive support for managing chronic kidney disease.
The 6th Annual AII DaVinci International Innovation and Invention Expo, hosted by the American Innovation & Invention Institute and Southern Utah University in 2025, is a prestigious platform for global innovation, attracting participants from more than ten countries, including the United States, Taiwan, China, Thailand and Canada.
SynbioTech innovations in precision health for an ageing population
SynbioTech possesses one of Asia's largest commercial lactic acid bacteria strain banks, with a collection exceeding 2000 strains.
"We are honoured by this recognition from the Da Vinci Expo. As we believe that better probiotics make our lives better, the R&D team at SynbioTech has grown swiftly and focused on cutting-edge developments in functional probiotics," said Mr Yang Lian-Chuan, President of SynbioTech.
"Those award-winning health products are scientifically proven to help boost immunity, protect joints, and support kidney health for the ageing population."
SYNTEK Thorough enhances probiotic potency by more than 50%
Mr Sean Yang, COO of SynbioTech, highlighted a key innovation: "SynbioTech's ABKEFIR, developed by our proprietary SYNTEK thorough procedure, combines five selected lactic acid strains from traditional kefir with two dominant gut bacteria."
"The breakthrough technology of 'Symbiotic Fermentation' increases the stability and concentration of probiotics by over 50%. Furthermore, human clinical trials have confirmed its effectiveness in regulating gut microbiota and alleviating gastrointestinal discomfort."
Another gold-medal highlight was the formula's proven ability to inhibit harmful bacteria such as Salmonella, a leading cause of fatal food poisoning worldwide.